Why Measure Your Clinical Boundary Risk?
Every healthcare organisation operates across organisational boundaries — referral pathways, discharge interfaces, diagnostic partnerships, insurer pre-authorisation flows. Each boundary is a point where patient data crosses between separate governance frameworks, where clinical responsibility transfers between independent organisations, and where the assumptions of one system meet the reality of another.
Existing governance frameworks — CQC, DCB 0129/0160, PSIRF, DSPT — assess safety within an organisation. None measures what happens between them. The result is a structural blind spot: boundaries where patient identity isn't verified on receipt, where clinical intent degrades from structured coding to free text, where responsibility is relinquished before it is accepted, and where outcome data never flows back.
Who should take this assessment?
Clinical Safety Officers whose hazard logs don't yet include boundary-specific risks. Private healthcare groups managing post-acquisition integration or NHS sub-contracting boundaries. PE investors and acquirers pricing governance risk across portfolio boundaries. Anyone accountable for clinical governance at the joins between organisations.
What the score tells you
This self-assessment evaluates your governance across the Seven Flows: Identity, Consent, Provenance, Clinical Intent, Alert & Responsibility, Service Routing, and Outcome — plus escalation mechanisms, constitutional awareness, and hazard log coverage. Your score is indicative, not diagnostic. It tells you whether boundary risk is material for your organisation and where the structural gaps are most likely.
A full Boundary Risk Assessment provides per-boundary scoring with cascading failure logic, statutory traceability, Constitutional Transition Analysis, and a funded remediation roadmap. The self-assessment tells you whether that conversation is worth having. In our experience, it almost always is.